PhaseBio Pharmaceuticals
Utility Patents

Last updated:

List of all PhaseBio Pharmaceuticals patents 7 in total

Status Patent
Grant
Utility: Methods and compositions for treating muscle disease and disorders External link
Filling date: 6 Sep 2025 Issue date: 8 Mar 2022
Grant
Utility: Metalloenzyme inhibitor compounds External link
Filling date: 6 Sep 2025 Issue date: 5 Oct 2021
Grant
Utility: Methods and compositions for treating cystic fibrosis External link
Filling date: 6 Sep 2025 Issue date: 6 Jul 2021
Grant
Utility: Metalloenzyme inhibitor compounds External link
Filling date: 6 Sep 2025 Issue date: 22 Jun 2021
Grant
Utility: Use of modified vasoactive intestinal peptides in the treatment of hypertension External link
Filling date: 6 Sep 2025 Issue date: 9 Mar 2021
Grant
Utility: ELP fusion proteins for controlled and sustained release External link
Filling date: 6 Sep 2025 Issue date: 28 Jul 2020
Grant
Utility: Methods and compositions for treating muscle disease and disorders External link
Filling date: 6 Sep 2025 Issue date: 23 Jun 2020

Showing 1 to 7 of 7 patents.